Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Vaccination 

Community pharmacy delivers more than 70,000 more flu vaccines during 2018/2019 season

The final number of flu vaccines given during the 2018/2019 flu season will not be confirmed until October 2019 at the earliest.

Flu vaccine

Source: Shutterstock.com

Community pharmacies submitting data into the PharmOutcomes, Well, Healthi and Sonar systems delivered 1,270,489 vaccinations in the 2018/2019 flu season — an increase of 71,221 patients compared with 2017/2018

Community pharmacies in England delivered more than 70,000 more flu vaccinations during the 2018/2019 flu season compared to 2017/2018, according to provisional figures published by the Pharmaceutical Services Negotiating Committee (PSNC).

During the 2018/2019 flu season, 1 September 2018 and ended on 31 March 2019, community pharmacies submitting data into the PharmOutcomes, Well, Healthi and Sonar systems delivered 1,270,489 vaccinations — an increase of 71,221 patients compared with the year before (n=1,199,268 patients).

This increase is despite pharmacists across England being forced to turn patients away in 2018 after staggered deliveries led to gaps in supply of the new adjuvanted trivalent flu vaccine.

However, the PSNC highlighted that not all contractors use these electronic systems to record administration of vaccines; therefore, the total number of vaccinations administered will be higher than the number recorded. In 2017/2018, for example, the final figure was 1,344,462 — 145,194 higher than the number recorded via the electronic systems. 

Also, owing to changes agreed for the 2018/2019 service, which allowed claims for payment to be accepted by the NHS Business Services Authority up to six months after the vaccination was given, the final number of vaccinations administered will not be confirmed until October 2019 at the earliest.

According to the provisional data for 2018/2019, patients aged over 65 years was the biggest group of eligible patients to be vaccinated during the 2018/2019 season, followed by those with chronic respiratory disease and those with diabetes.

Public Health England plans to extend the vaccination programme for the 2019/2020 flu season to children in school year six meaning that, for the first time in England, all primary school aged children will be offered the vaccine.

Further to this, a newly licensed cell-based quadrivalent influenza vaccine (QIVc) will be offered to patients aged 18 years and over.

A high dose trivalent influenza vaccine, which has been deemed suitable for those aged 65 years and over, has now been licensed for use in the UK but it is not eligible for reimbursement under the NHS flu vaccination programme because it has a significantly higher list price than the equally suitable vaccines.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2019.20206377

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.